Literature DB >> 30159748

Autonomic testing: which value for each cardiovascular test? An observational study.

Federico Bellavere1, Eugenio Ragazzi2, Nino Cristiano Chilelli3, Annunziata Lapolla3, Giuseppe Bax4.   

Abstract

AIMS: Cardiovascular autonomic testing is time consuming when adopting the entire Ewing battery of tests, hence, clinicians usually adopt an empirically reduced number of tests which may give controversial results. Our purpose was to examine the reliability of the cardiovascular tests most commonly used in autonomic diagnoses.
METHODS: We tested 334 subjects, from an original group of 3745, who had shown an altered deep breathing test to both Lying to standing and Valsalva manoeuvre, assuming a value of postural hypotension of more than 15 mmHg as a sign of almost true dysautonomia.
RESULTS: VM showed the highest sensitivity (85%) and, when coupled to LS, highest specificity (83%).
CONCLUSIONS: VM could be useful when screening for possible or early autonomic neuropathy, VM + LS is useful as a diagnostic tool for probable or advanced autonomic neuropathy, and VM + LS + PH is useful for certain diagnosis of definite or late stage autonomic neuropathy.

Entities:  

Keywords:  Autonomic neuropathy; Cardiovascular tests; Diabetic neuropathy; Postural hypotension

Mesh:

Year:  2018        PMID: 30159748     DOI: 10.1007/s00592-018-1215-y

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  3 in total

Review 1.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

2.  Noninvasive exploration of Cardiac Autonomic Neuropathy by heart rate and blood pressure variability analysis in Type 2 Diabetic patients.

Authors:  Tallat Naz; Noor Un Nisa Memon; Kamran Afzal; Ambreen Shakir
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

3.  Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus.

Authors:  Kalliopi Pafili; Grigorios Trypsianis; Dimitrios Papazoglou; Efstratios Maltezos; Nikolaos Papanas
Journal:  Diabetes Ther       Date:  2020-03-14       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.